Clinical impact of the CYP3A5 6986A>G allelic variant on kidney transplantation outcomes.
about
Genetics of acute rejection after kidney transplantation.CYP3A genotypes of donors but not those of the patients increase the risk of acute rejection in renal transplant recipients on calcineurin inhibitors: a pilot study.CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment.
P2860
Clinical impact of the CYP3A5 6986A>G allelic variant on kidney transplantation outcomes.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Clinical impact of the CYP3A5 6986A>G allelic variant on kidney transplantation outcomes.
@en
Clinical impact of the CYP3A5 6986A>G allelic variant on kidney transplantation outcomes.
@nl
type
label
Clinical impact of the CYP3A5 6986A>G allelic variant on kidney transplantation outcomes.
@en
Clinical impact of the CYP3A5 6986A>G allelic variant on kidney transplantation outcomes.
@nl
prefLabel
Clinical impact of the CYP3A5 6986A>G allelic variant on kidney transplantation outcomes.
@en
Clinical impact of the CYP3A5 6986A>G allelic variant on kidney transplantation outcomes.
@nl
P2860
P50
P356
P1433
P1476
Clinical impact of the CYP3A5 6986A>G allelic variant on kidney transplantation outcomes.
@en
P2093
Dany Anglicheau
Eric Thervet
P2860
P304
P356
10.2217/PGS-2016-0146
P577
2016-12-15T00:00:00Z